Schonfeld Strategic Advisors LLC Homology Medicines, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $187,985 - $303,400	-20,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $182,860 - $272,445	20,500 New	20,500 $232,000
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $287,784 - $559,188	-25,200 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $511,478 - $773,116	-34,700 Reduced 57.93%	25,200 $455,000
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $1.1 Million - $1.82 Million	59,900 New	59,900 $1.17 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.